A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

December 31, 2014

Conditions
Gastric Cancer
Interventions
BIOLOGICAL

LY2875358

Administered IV

Trial Locations (3)

464-8681

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Aichi

565-0871

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Osaka

135 720

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seoul

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01874938 - A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter